woman standing confidently with a warm expression

woman standing confidently with a warm expression

What is
Mounjaro
(tirzepatide)

true
Mounjaro (tirzepatide) is the first and only approved type 2 diabetes medicine of its kind—activating the receptors of two key hormones to help lower blood sugar levels in adults and children 10 years of age and older with type 2 diabetes, along with diet and exercise.
true
ON THIS PAGE

What is Mounjaro

What is Mounjaro

what-is-mounjaro

How Mounjaro works

How Mounjaro works

how-mounjaro-works

Mounjaro comparison

Mounjaro comparison

mounjaro-comparison

backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
enableTarget
true
target-Id
hero-banner-default

woman standing confidently with a warm expression

woman standing confidently with a warm expression

What is
Mounjaro
(tirzepatide)

true
Mounjaro (tirzepatide) is the first and only approved type 2 diabetes medicine of its kind—activating the receptors of two key hormones to help lower blood sugar levels in adults and children 10 years of age and older with type 2 diabetes, along with diet and exercise.
How to save on Mounjaro
true
ON THIS PAGE

What is Mounjaro

What is Mounjaro

what-is-mounjaro

For type 2 diabetes

For type 2 diabetes

for-type-2-diabetes

How Mounjaro works

How Mounjaro works

how-mounjaro-works

Mounjaro comparison

Mounjaro comparison

mounjaro-comparison

backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
enableTarget
true
hideblocks
true
target-Id
hero-banner-personalized
4
1
WHAT IS MOUNJARO?

_Mounjaro is the first and only approved treatment in a different class of medication for type 2 diabetes. *_

5
3
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus.

It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
*It works differently than other type 2 diabetes medications by directly activating GIP and GLP-1 pathways to help regulate blood sugar.

GIP=glucose-dependent insulinotropic polypeptide; GLP-1=glucagon-like peptide-1.
4
1
text
what-is-mounjaro
backgroundOption
color
backgroundColor
background-surface-2
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-stretch, inner-color, two-col-80-20
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
4
1

_Mounjaro for type 2 diabetes_

text
for-type-2-diabetes
backgroundOption
color
backgroundColor
background-none
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-stretch, inner-color, two-col-90-10
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
3
0
Up to 90% of adults taking Mounjaro reached an A1C
5
3
under 7%
3
0
backgroundOption
color
backgroundColor
background-none
image
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:26b7f54a-237f-4392-9780-67850a2ab507/as/under-7-percent_device_vial_desktop.avif?assetname=under+7+percent_device_vial_desktop.jpg
style
inner-background-surface-1, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-center, inner-image, inner-text-auto, two-col-50-50
textColor
auto
extra-styles
offset
additionalPadding
none
additionalMargin
none
enableinnercontainer
true
innerimage
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:a97132fa-e47f-4284-ac1c-c889ae05dc7f/as/under-7-percent_device_desktop.avif?assetname=under+7+percent_device_desktop.jpg
innerimagealternativetext
Mounjaro 10mg device on purple background
mobinnerimage
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:c5d07858-f319-4af0-b697-f10d49aba140/as/under-7-percent_device_mobile.avif?assetname=under+7+percent_device_mobile.jpg
mobinnerimagealternativetext
Mounjaro 10mg device on purple background
roundedBorderscolumncontainer
true
†In studies with or without other diabetes medications, the percentage of adults taking Mounjaro who reached an A1C of less than 7% ranged from 75% (5 mg) to 90% (10 mg). Adults had an average starting A1C of 7.9% to 8.6% across the 
5-mg, 10-mg, and 15-mg doses. A 40-week study was conducted to see if Mounjaro 5-mg, 10-mg, and 15-mg plus a basal insulin worked better than basal insulin alone. 90% of adults taking Mounjaro 10-mg plus basal insulin achieved an A1C of under 7%.
4
2
Warning icon

_Select Important Safety Information_

Mounjaro can cause serious side effects, including: Inflammation of your pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back.
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
true
Adults taking
Mounjaro lost up to
25 lbs
backgroundOption
color
backgroundColor
background-none
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-center, inner-image, inner-text-manual, inner-color-white, three-col-25-25-50
textColor
auto
additionalPadding
none
additionalMargin
none
enableinnercontainer
true
innerimage
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:f0b7077a-e03e-4e91-8723-b0d184d16338/as/25-lb-claim_gradient_desktop.avif?assetname=25+lb+claim_gradient_desktop.jpg
innerimagealternativetext
mountain graphic purple gradient header
mobinnerimage
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:ff126677-896e-42db-93f5-16114ada1cdd/as/25-lb-claim_gradient_mobile.avif?assetname=25+lb+claim_gradient_mobile.jpg
mobinnerimagealternativetext
mountain graphic purple gradient header
roundedBorderscolumncontainer
true
Mounjaro is not a weight loss drug.

‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
4
2
warning icon

_Select Important Safety Information_

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery.
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
4
1
_Mounjaro works in multiple ways._
Mounjaro helps your body regulate blood sugar and decrease how much food you eat

Mounjaro helps:
4
3
up arrow icon
icon-card-item, desktopiconwidth-64px, mobileiconwidth-64px, highlightcolor-surface-inverse-2, title-fs-24px, description-fs-24px, ctanumber-one, ctatype-button, ctacolor-light, ctastyle-primary, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatype-button-two, ctacolor-light-two, ctastyle-primary-two, ctaselection-link-two, ctatarget-sametab-two, ctaexitinterstitial-select-two
up arrow icon
The body release insulin when blood sugar is high
minus circle icon
icon-card-item, desktopiconwidth-64px, mobileiconwidth-64px, highlightcolor-surface-inverse-2, description-fs-24px, ctanumber-one, ctatype-button, ctacolor-light, ctastyle-primary, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatype-button-two, ctacolor-light-two, ctastyle-primary-two, ctaselection-link-two, ctatarget-sametab-two, ctaexitinterstitial-select-two
minus circle icon
The body remove excess sugar from the blood
2
2
line through circle icon
icon-card-item, desktopiconwidth-64px, mobileiconwidth-64px, highlightcolor-surface-inverse-2, description-fs-24px, ctanumber-one, ctatype-button, ctacolor-light, ctastyle-primary, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatype-button-two, ctacolor-light-two, ctastyle-primary-two, ctaselection-link-two, ctatarget-sametab-two, ctaexitinterstitial-select-two
line through circle icon
Stop the liver from making and releasing too much sugar
fork and knife icon
icon-card-item, desktopiconwidth-64px, mobileiconwidth-64px, highlightcolor-surface-inverse-2, description-fs-24px, ctanumber-one, ctatype-button, ctacolor-light, ctastyle-primary, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatype-button-two, ctacolor-light-two, ctastyle-primary-two, ctaselection-link-two, ctatarget-sametab-two, ctaexitinterstitial-select-two
fork and knife icon
Stop the liver from making and releasing too much sugar
2
2
down arrow icon
icon-card-item, desktopiconwidth-64px, mobileiconwidth-64px, highlightcolor-surface-inverse-2, description-fs-24px, ctanumber-one, ctatype-button, ctacolor-light, ctastyle-primary, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctatype-button-two, ctacolor-light-two, ctastyle-primary-two, ctaselection-link-two, ctatarget-sametab-two, ctaexitinterstitial-select-two
down arrow icon
Slow down how quickly food leaves the stomach. This lessens over time
4
2
You can learn about possible side effects of Mounjaro here.
4
2
warning icon

_Select Important Safety Information_

Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including: swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
4
1
text
how-mounjaro-works
backgroundOption
color
backgroundColor
background-surface-1
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
4
1

_See how Mounjaro compares against competitors like Ozempic_

In clinical studies, Mounjaro was compared to some other medicines for type 2 diabetes.
text
mounjaro-comparison
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
0
0

_Mounjaro A1C results_

0
0
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
Mounjaro vs Ozempic®
mounjaro-vs-ozempic
Mounjaro vs Tresiba®
mounjaro-vs-tresiba
Mounjaro vs Placebo
mounjaro-vs-placebo
style
tabs-container-background-none
_Mounjaro vs Ozempic®_
Ozempic 2 mg was not available at the time of the study.
In a 40-week study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to Ozempic 1 mg in 1879 adults with type 2 diabetes who were also taking metformin and had a starting A1C of 8.3%.
2
1
bar chart comparing a1c reductions for mounjaro doses vs ozempic 1 mg
bar chart comparing a1c reductions for mounjaro doses vs ozempic 1 mg

Image description

For people taking Mounjaro, their A1C was lowered on average by 2.0% on the 5-mg dose, 2.2% on the 10-mg dose, and 2.3% on the 15-mg dose. For people taking the Ozempic 1-mg dose, their A1C was lowered on average by 1.9%.

true
4
2
1
1
text
mounjaro-vs-ozempic
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
_Mounjaro vs Tresiba®_
In a 52-week study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to titrated Tresiba, a basal insulin, in 1444 adults with type 2 diabetes who were also taking metformin with or without another oral diabetes medication. They had an average starting A1C of 8.1 to 8.2%. At the end of the study, 26% of people on Tresiba met the blood sugar goal (or target). The average daily dose of Tresiba was 49 units per day by the end of the study.
2
1
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png

Image description

For adults taking Mounjaro, their A1C was lowered by 1.9% on the 5-mg dose, 2.0% on the 10-mg dose, and 2.1% on the 15-mg dose. For adults taking Tresiba, their A1C was lowered by 1.3%.

true
4
2
1
1
text
mounjaro-vs-tresiba
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
_Mounjaro vs Placebo_
In a 40-week study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to placebo in 475 adults with type 2 diabetes who were also taking insulin glargine. Some study participants were also taking metformin. They had a starting A1C of 8.2% to 8.4%.
2
1
bar chart showing insulin glargine lowered A1C on Mounjaro vs placebo by dose
bar chart showing insulin glargine lowered A1C on Mounjaro vs placebo by dose

Image description

For adults taking Mounjaro and insulin glargine, their A1C was lowered by 2.1% on the 5-mg dose, 2.4% on the 10-mg dose, and 2.3% on the 15-mg dose. For adults taking placebo and insulin glargine, their A1C was lowered by 0.9%.

true
2
1
0
0

_Select Important Safety Information_

Warning:

Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.
Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery

4
2
1
1
text
mounjaro-vs-placebo
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none

_Mounjaro weight results_

0
0
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
Mounjaro vs Ozempic®
mounjaro-vs-ozempic-weight
Mounjaro vs Tresiba®
mounjaro-vs-tresiba-weight
Mounjaro vs Placebo
mounjaro-vs-placebo-weight
style
tabs-container-background-none
_Mounjaro vs Ozempic®_
Ozempic 2 mg was not available at the time of the study.
*Mounjaro is not a weight loss drug.
 Individual results may vary. In this study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to Ozempic 1 mg. The average starting weight was between 204 to 209 pounds.
2
1
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png

Image description

People taking Mounjaro saw an average weight loss of 17 pounds on the 5-mg dose, 21 pounds on the 10-mg dose, and 25 pounds on the 15-mg dose. Those taking the Ozempic 1-mg dose saw an average weight loss of 13 pounds.

true
4
2

_Select Important Safety Information_

Warning:

Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.

text
mounjaro-vs-ozempic-weight
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
_Mounjaro vs Tresiba®_
*Mounjaro is not a weight loss drug.
Individual results may vary. In this study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to titrated Tresiba, a basal insulin commonly associated with weight gain. All participants also took metformin with or without another oral diabetes medication. The average starting weight was between 207 to 209 pounds.
2
1
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png

Image description

Adults taking Mounjaro saw an average weight loss of 15 pounds on the 5-mg dose, 21 pounds on the 10-mg dose, and 25 pounds on the 15-mg dose. Those taking Tresiba saw an average weight gain of 4 pounds.

true
4
2

_Select Important Safety Information_

Warning:

Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

text
mounjaro-vs-tresiba-weight
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
_Mounjaro vs Placebo_
*Mounjaro is not a weight loss drug.
Individual results may vary. In this study, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to placebo. Study participants were also taking insulin glargine, a medication commonly associated with weight gain. Some study participants were also taking metformin. The average starting weight was between 208 to 212 pounds.
2
1
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png
US OFG WM EFFICACY WEIGHT 5 AND 10PERCENT BAR GRAPH M.png

Image description

Adults taking Mounjaro plus insulin glargine saw an average weight loss of 12 pounds on the 5-mg dose, 17 pounds on the 10-mg dose, and 19 pounds on the 15-mg dose. Those taking insulin glargine and placebo gained an average of 4 pounds.

true
2
1
0
0

_Select Important Safety Information_

Warning:

Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.
Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery.

text
mounjaro-vs-placebo-weight
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
4
1
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
4
1

Talk to your doctor about Mounjaro at your next visit

4
1
backgroundOption
image
backgroundColor
background-none
image
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:aa08de6d-31f5-4a94-91e6-4bd71bf1789d/as/talk-to-your-doctor_gradient_desktop.avif?assetname=talk+to+your+doctor_gradient_desktop.jpg
imagealternativetext
Purple gradient background
mobileImage
https://delivery-p137454-e1438138.adobeaemcloud.com/adobe/assets/urn:aaid:aem:db5873dd-cddc-4eda-9d04-d472c9cc4fca/as/talk-to-your-doctor_gradient_mobile.avif?assetname=talk+to+your+doctor_gradient_mobile.jpg
mobimagealternativetext
Purple gradient background
textColor
manual
color
white
additionalPadding
narrow-all
additionalMargin
none
4
1
SUPPORTING YOUR JOURNEY

_Helpful resources for you_

backgroundOption
color
backgroundColor
background-surface-1
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-end, inner-color, two-col-75-25
textColor
auto
extra-styles
offset
additionalPadding
narrow-top
additionalMargin
none
4
1
backgroundOption
color
backgroundColor
background-surface-1
textColor
auto
additionalPadding
none
additionalMargin
none
Get tools, insights, and guidance that may help throughout your Mounjaro journey.
Explore all resources
backgroundOption
color
backgroundColor
background-surface-1
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-center, inner-color, two-col-50-50
textColor
auto
extra-styles
offset
additionalPadding
none
additionalMargin
none
card, highlightcolor-surface-inverse-2, ctatype-textlink, ctacolor-light, ctastyle-primary, ctatarget-sametab, ctaexitinterstitial-select, ctatype-textlink-two, ctacolor-light-two, ctastyle-primary-two, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
man smiling warmly while looking ahead
FIND CARE
0
0

_Getting the care you need can be quick and accessible_

Explore speed, convenience, and access to focused care with independent telehealth or in-person providers.
2
1
In-person care
Telehealth
card, highlightcolor-surface-inverse-2, ctatype-textlink, ctacolor-light, ctastyle-primary, ctatarget-sametab, ctaexitinterstitial-select, ctatype-textlink-two, ctacolor-light-two, ctastyle-primary-two, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Man sitting with his kids on the floor
SAVINGS OPTIONS
0
0

_Mounjaro Savings Program_

Eligible, commercially insured patients with Mounjaro coverage can pay as little as $25 for up to a 3-month prescription with the Mounjaro Savings Program.

Governmental beneficiaries excluded. Eligibility required, terms and conditions apply. Savings subject to monthly and annual limits. Month is defined as 28-days and up to 4 pens. Card eligibility and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. PROGRAM IS NOT INSURANCE.

Review full terms and conditions at https://mounjaro.lilly.com/savings-coverage#special-terms-and-conditions.

2
1
Learn more
backgroundOption
color
backgroundColor
background-surface-1
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-stretch, inner-color, two-col-50-50
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
enableTarget
true
target-Id
helpful-resources-default
card, highlightcolor-surface-inverse-2, ctatype-textlink, ctacolor-light, ctastyle-primary, ctatarget-sametab, ctaexitinterstitial-select, ctatype-textlink-two, ctacolor-light-two, ctastyle-primary-two, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
Man sitting with his kids on the floor
SAVINGS INFO
0
0

_Mounjaro Savings Program_

Eligible, commercially insured patients with Mounjaro coverage can pay as little as $25 for up to a 3-month prescription with the Mounjaro Savings Program.

Governmental beneficiaries excluded. Eligibility required, terms and conditions apply. Savings subject to monthly and annual limits. Month is defined as 28-days and up to 4 pens. Card eligibility and terms and conditions may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. PROGRAM IS NOT INSURANCE.

Review full terms and conditions at https://mounjaro.lilly.com/savings-coverage#special-terms-and-conditions.

2
1
Learn more
card, highlightcolor-surface-inverse-2, ctatype-textlink, ctacolor-light, ctastyle-primary, ctatarget-sametab, ctaexitinterstitial-select, ctatype-textlink-two, ctacolor-light-two, ctastyle-primary-two, ctatarget-sametab-two, ctaexitinterstitial-select-two, ctanumber-one
man smiling warmly while looking ahead
FIND CARE
0
0

_Getting the care you need can be quick and accessible_

Explore speed, convenience, and access to focused care with independent telehealth or in-person providers.
2
1
In-person care
Telehealth
backgroundOption
color
backgroundColor
background-surface-1
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-stretch, inner-color, two-col-50-50
textColor
auto
additionalPadding
narrow-all
additionalMargin
none
enableTarget
true
hideblocks
true
target-Id
helpful-resources-personalized
4
1
backgroundOption
color
backgroundColor
background-surface-1
textColor
auto
additionalPadding
none
additionalMargin
none